Q Biotech Corp Appoints David Briggs, PhD, as Strategic Advisor, Corporate Development
Rio Rancho, NM — April 20, 2026 — Q Biotech Corp, a leading innovator in life science technologies, today announced the appointment of David Briggs, PhD, as Strategic Advisor to the company. In this role, Dr. Briggs will support the company’s commercial growth strategy following the development of its proprietary protein separation technology, Inceptum™.
Q Biotech Corp Appoints David Briggs, PhD, as Strategic Advisor, Corporate Development
Rio Rancho, NM — April 20, 2026 — Q Biotech Corp, a leading innovator in life science technologies, today announced the appointment of David Briggs, PhD, as Strategic Advisor to the company. In this role, Dr. Briggs will support the company’s commercial growth strategy following the development of its proprietary protein separation technology, Inceptum™.
Dr. Briggs brings more than 20 years of experience in life science product development and commercialization. He is the founder of Rapid Product Marketing Solutions, where he has advised organizations on accelerating product-market fit and driving revenue growth. Prior to this, Dr. Briggs held senior marketing and business leadership roles at MilliporeSigma and Thermo Fisher Scientific, where he led successful product launches and growth initiatives across global markets.
“David’s depth of experience in translating innovative technologies into commercial success makes him an outstanding addition to our team,” said Sergey Dryga, PhD, MBA, Founder and CEO of Q Biotech. “As we move into the next phase of company growth following the successful development of Inceptum, his strategic insight and commercial perspective will help us expand our market presence and deliver value to customers.”
“I’m excited to join Q Biotech as Strategic Advisor at such an important stage in its evolution,” said Dr. Briggs. “Inceptum represents a compelling advancement in research and process development by expanding the reach of clean, reproducible, automated purification system to a wider customer base, and I look forward to helping bring this innovation to market and scale its impact across the life sciences industry.”
Dr. Briggs holds a PhD in Molecular Parasitology and will work closely with Q Biotech’s leadership team to support the company’s commercialization efforts.
About Q Biotech Corp
Q Biotech Corp is a life sciences company dedicated to making high-quality biomolecule purification simple, fast, and accessible. Founded in 2022 and headquartered in Rio Rancho, New Mexico, the company designs innovative tools that streamline research and production workflows for proteins, RNA, and DNA. Its flagship platform, the Inceptum™ personal chromatography system, combines fully automated operation with disposable cartridges, eliminating the complexity, cleanup, and cross-contamination risks of traditional systems.
Media Contact:
Bob Evans
VP Business Development
Q Biotech Corp
bevans@q-biotech.com